nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethosuximide—CYP3A7—Tretinoin—peripheral nervous system neoplasm	0.119	0.154	CbGbCtD
Ethosuximide—CYP3A7-CYP3A51P—Tretinoin—peripheral nervous system neoplasm	0.119	0.154	CbGbCtD
Ethosuximide—CYP2E1—Dacarbazine—peripheral nervous system neoplasm	0.099	0.127	CbGbCtD
Ethosuximide—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.0895	0.115	CbGbCtD
Ethosuximide—CYP3A7—Vincristine—peripheral nervous system neoplasm	0.0548	0.0705	CbGbCtD
Ethosuximide—CYP3A7-CYP3A51P—Vincristine—peripheral nervous system neoplasm	0.0548	0.0705	CbGbCtD
Ethosuximide—CYP2E1—Etoposide—peripheral nervous system neoplasm	0.0484	0.0624	CbGbCtD
Ethosuximide—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.0411	0.0529	CbGbCtD
Ethosuximide—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.0376	0.0485	CbGbCtD
Ethosuximide—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0375	0.0483	CbGbCtD
Ethosuximide—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0349	0.0449	CbGbCtD
Ethosuximide—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.016	0.0206	CbGbCtD
Ethosuximide—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0147	0.0189	CbGbCtD
Ethosuximide—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.01	0.0129	CbGbCtD
Ethosuximide—Urinary tract disorder—Cisplatin—peripheral nervous system neoplasm	0.000574	0.00257	CcSEcCtD
Ethosuximide—Leukopenia—Dactinomycin—peripheral nervous system neoplasm	0.000573	0.00257	CcSEcCtD
Ethosuximide—Connective tissue disorder—Cisplatin—peripheral nervous system neoplasm	0.000571	0.00256	CcSEcCtD
Ethosuximide—Urethral disorder—Cisplatin—peripheral nervous system neoplasm	0.00057	0.00255	CcSEcCtD
Ethosuximide—Somnolence—Tretinoin—peripheral nervous system neoplasm	0.000569	0.00255	CcSEcCtD
Ethosuximide—Somnolence—Isotretinoin—peripheral nervous system neoplasm	0.000569	0.00255	CcSEcCtD
Ethosuximide—Decreased appetite—Topotecan—peripheral nervous system neoplasm	0.000561	0.00251	CcSEcCtD
Ethosuximide—Aplastic anaemia—Epirubicin—peripheral nervous system neoplasm	0.000558	0.0025	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.000557	0.00249	CcSEcCtD
Ethosuximide—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	0.000556	0.00249	CcSEcCtD
Ethosuximide—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	0.000556	0.00249	CcSEcCtD
Ethosuximide—Fatigue—Topotecan—peripheral nervous system neoplasm	0.000556	0.00249	CcSEcCtD
Ethosuximide—Agranulocytosis—Etoposide—peripheral nervous system neoplasm	0.000554	0.00248	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.000552	0.00247	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.000552	0.00247	CcSEcCtD
Ethosuximide—Fatigue—Isotretinoin—peripheral nervous system neoplasm	0.000552	0.00247	CcSEcCtD
Ethosuximide—Fatigue—Tretinoin—peripheral nervous system neoplasm	0.000552	0.00247	CcSEcCtD
Ethosuximide—Hiccups—Doxorubicin—peripheral nervous system neoplasm	0.00055	0.00246	CcSEcCtD
Ethosuximide—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.000549	0.00246	CcSEcCtD
Ethosuximide—Agitation—Alitretinoin—peripheral nervous system neoplasm	0.000546	0.00245	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.000545	0.00244	CcSEcCtD
Ethosuximide—Fatigue—Melphalan—peripheral nervous system neoplasm	0.000544	0.00244	CcSEcCtD
Ethosuximide—Eye disorder—Cisplatin—peripheral nervous system neoplasm	0.000543	0.00243	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.000527	0.00236	CcSEcCtD
Ethosuximide—Urinary tract disorder—Etoposide—peripheral nervous system neoplasm	0.000526	0.00236	CcSEcCtD
Ethosuximide—Agitation—Vincristine—peripheral nervous system neoplasm	0.000526	0.00236	CcSEcCtD
Ethosuximide—Immune system disorder—Cisplatin—peripheral nervous system neoplasm	0.000525	0.00235	CcSEcCtD
Ethosuximide—Mediastinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000524	0.00235	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.000523	0.00234	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.000523	0.00234	CcSEcCtD
Ethosuximide—Urethral disorder—Etoposide—peripheral nervous system neoplasm	0.000522	0.00234	CcSEcCtD
Ethosuximide—Aplastic anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000517	0.00231	CcSEcCtD
Ethosuximide—Mental disability—Epirubicin—peripheral nervous system neoplasm	0.000516	0.00231	CcSEcCtD
Ethosuximide—Leukopenia—Vincristine—peripheral nervous system neoplasm	0.000512	0.0023	CcSEcCtD
Ethosuximide—Urticaria—Topotecan—peripheral nervous system neoplasm	0.000512	0.00229	CcSEcCtD
Ethosuximide—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.00051	0.00228	CcSEcCtD
Ethosuximide—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.000508	0.00228	CcSEcCtD
Ethosuximide—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.000508	0.00228	CcSEcCtD
Ethosuximide—Malnutrition—Cisplatin—peripheral nervous system neoplasm	0.000506	0.00227	CcSEcCtD
Ethosuximide—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.000506	0.00227	CcSEcCtD
Ethosuximide—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.000506	0.00227	CcSEcCtD
Ethosuximide—Erythema multiforme—Etoposide—peripheral nervous system neoplasm	0.000504	0.00226	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.000502	0.00225	CcSEcCtD
Ethosuximide—Urticaria—Melphalan—peripheral nervous system neoplasm	0.000502	0.00225	CcSEcCtD
Ethosuximide—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.000498	0.00223	CcSEcCtD
Ethosuximide—Eye disorder—Etoposide—peripheral nervous system neoplasm	0.000498	0.00223	CcSEcCtD
Ethosuximide—Muscle spasms—Cisplatin—peripheral nervous system neoplasm	0.000487	0.00218	CcSEcCtD
Ethosuximide—Immune system disorder—Etoposide—peripheral nervous system neoplasm	0.000481	0.00216	CcSEcCtD
Ethosuximide—Mediastinal disorder—Etoposide—peripheral nervous system neoplasm	0.00048	0.00215	CcSEcCtD
Ethosuximide—Mental disability—Doxorubicin—peripheral nervous system neoplasm	0.000477	0.00214	CcSEcCtD
Ethosuximide—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.000475	0.00213	CcSEcCtD
Ethosuximide—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000475	0.00213	CcSEcCtD
Ethosuximide—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000471	0.00211	CcSEcCtD
Ethosuximide—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000471	0.00211	CcSEcCtD
Ethosuximide—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.000471	0.00211	CcSEcCtD
Ethosuximide—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000465	0.00208	CcSEcCtD
Ethosuximide—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000463	0.00207	CcSEcCtD
Ethosuximide—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.000462	0.00207	CcSEcCtD
Ethosuximide—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000459	0.00206	CcSEcCtD
Ethosuximide—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000459	0.00206	CcSEcCtD
Ethosuximide—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.000458	0.00205	CcSEcCtD
Ethosuximide—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000455	0.00204	CcSEcCtD
Ethosuximide—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.000453	0.00203	CcSEcCtD
Ethosuximide—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000453	0.00203	CcSEcCtD
Ethosuximide—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000451	0.00202	CcSEcCtD
Ethosuximide—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.000446	0.002	CcSEcCtD
Ethosuximide—Anorexia—Vincristine—peripheral nervous system neoplasm	0.000445	0.00199	CcSEcCtD
Ethosuximide—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000441	0.00198	CcSEcCtD
Ethosuximide—Lethargy—Epirubicin—peripheral nervous system neoplasm	0.00044	0.00197	CcSEcCtD
Ethosuximide—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000438	0.00196	CcSEcCtD
Ethosuximide—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000438	0.00196	CcSEcCtD
Ethosuximide—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000432	0.00194	CcSEcCtD
Ethosuximide—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000431	0.00193	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000428	0.00192	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000428	0.00192	CcSEcCtD
Ethosuximide—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000426	0.00191	CcSEcCtD
Ethosuximide—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000423	0.00189	CcSEcCtD
Ethosuximide—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000423	0.00189	CcSEcCtD
Ethosuximide—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000421	0.00189	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000419	0.00187	CcSEcCtD
Ethosuximide—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000418	0.00187	CcSEcCtD
Ethosuximide—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.000415	0.00186	CcSEcCtD
Ethosuximide—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000413	0.00185	CcSEcCtD
Ethosuximide—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00041	0.00184	CcSEcCtD
Ethosuximide—Lethargy—Doxorubicin—peripheral nervous system neoplasm	0.000408	0.00183	CcSEcCtD
Ethosuximide—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000407	0.00182	CcSEcCtD
Ethosuximide—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000407	0.00182	CcSEcCtD
Ethosuximide—Rash—Topotecan—peripheral nervous system neoplasm	0.000407	0.00182	CcSEcCtD
Ethosuximide—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000406	0.00182	CcSEcCtD
Ethosuximide—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000406	0.00182	CcSEcCtD
Ethosuximide—Ataxia—Epirubicin—peripheral nervous system neoplasm	0.000406	0.00182	CcSEcCtD
Ethosuximide—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000405	0.00181	CcSEcCtD
Ethosuximide—Headache—Topotecan—peripheral nervous system neoplasm	0.000404	0.00181	CcSEcCtD
Ethosuximide—Rash—Tretinoin—peripheral nervous system neoplasm	0.000403	0.00181	CcSEcCtD
Ethosuximide—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000403	0.00181	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000403	0.00181	CcSEcCtD
Ethosuximide—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000403	0.00181	CcSEcCtD
Ethosuximide—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000403	0.00181	CcSEcCtD
Ethosuximide—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000403	0.0018	CcSEcCtD
Ethosuximide—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000401	0.0018	CcSEcCtD
Ethosuximide—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000401	0.0018	CcSEcCtD
Ethosuximide—Headache—Tretinoin—peripheral nervous system neoplasm	0.000401	0.0018	CcSEcCtD
Ethosuximide—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000401	0.0018	CcSEcCtD
Ethosuximide—Rash—Melphalan—peripheral nervous system neoplasm	0.000398	0.00178	CcSEcCtD
Ethosuximide—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000398	0.00178	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000396	0.00178	CcSEcCtD
Ethosuximide—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	0.000394	0.00177	CcSEcCtD
Ethosuximide—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000394	0.00176	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000392	0.00176	CcSEcCtD
Ethosuximide—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.00039	0.00175	CcSEcCtD
Ethosuximide—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000385	0.00173	CcSEcCtD
Ethosuximide—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000385	0.00173	CcSEcCtD
Ethosuximide—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000383	0.00172	CcSEcCtD
Ethosuximide—Nausea—Topotecan—peripheral nervous system neoplasm	0.000383	0.00172	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000382	0.00171	CcSEcCtD
Ethosuximide—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00038	0.0017	CcSEcCtD
Ethosuximide—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00038	0.0017	CcSEcCtD
Ethosuximide—Ataxia—Doxorubicin—peripheral nervous system neoplasm	0.000376	0.00168	CcSEcCtD
Ethosuximide—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000375	0.00168	CcSEcCtD
Ethosuximide—Nausea—Melphalan—peripheral nervous system neoplasm	0.000375	0.00168	CcSEcCtD
Ethosuximide—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.000369	0.00165	CcSEcCtD
Ethosuximide—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000369	0.00165	CcSEcCtD
Ethosuximide—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000368	0.00165	CcSEcCtD
Ethosuximide—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.000365	0.00163	CcSEcCtD
Ethosuximide—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000361	0.00162	CcSEcCtD
Ethosuximide—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000361	0.00162	CcSEcCtD
Ethosuximide—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000359	0.00161	CcSEcCtD
Ethosuximide—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000358	0.0016	CcSEcCtD
Ethosuximide—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000357	0.0016	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000357	0.0016	CcSEcCtD
Ethosuximide—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.000354	0.00159	CcSEcCtD
Ethosuximide—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000348	0.00156	CcSEcCtD
Ethosuximide—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000344	0.00154	CcSEcCtD
Ethosuximide—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000342	0.00153	CcSEcCtD
Ethosuximide—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000337	0.00151	CcSEcCtD
Ethosuximide—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000336	0.00151	CcSEcCtD
Ethosuximide—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000335	0.0015	CcSEcCtD
Ethosuximide—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000333	0.00149	CcSEcCtD
Ethosuximide—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000332	0.00149	CcSEcCtD
Ethosuximide—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000332	0.00149	CcSEcCtD
Ethosuximide—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.00033	0.00148	CcSEcCtD
Ethosuximide—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00033	0.00148	CcSEcCtD
Ethosuximide—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000329	0.00147	CcSEcCtD
Ethosuximide—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000328	0.00147	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000327	0.00146	CcSEcCtD
Ethosuximide—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000326	0.00146	CcSEcCtD
Ethosuximide—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000321	0.00144	CcSEcCtD
Ethosuximide—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00032	0.00143	CcSEcCtD
Ethosuximide—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000317	0.00142	CcSEcCtD
Ethosuximide—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000312	0.0014	CcSEcCtD
Ethosuximide—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000311	0.00139	CcSEcCtD
Ethosuximide—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.00031	0.00139	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000309	0.00139	CcSEcCtD
Ethosuximide—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000309	0.00138	CcSEcCtD
Ethosuximide—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000308	0.00138	CcSEcCtD
Ethosuximide—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000308	0.00138	CcSEcCtD
Ethosuximide—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000306	0.00137	CcSEcCtD
Ethosuximide—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000305	0.00137	CcSEcCtD
Ethosuximide—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000305	0.00137	CcSEcCtD
Ethosuximide—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000304	0.00136	CcSEcCtD
Ethosuximide—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000304	0.00136	CcSEcCtD
Ethosuximide—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000301	0.00135	CcSEcCtD
Ethosuximide—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000299	0.00134	CcSEcCtD
Ethosuximide—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000297	0.00133	CcSEcCtD
Ethosuximide—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000296	0.00133	CcSEcCtD
Ethosuximide—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000295	0.00132	CcSEcCtD
Ethosuximide—Rash—Vincristine—peripheral nervous system neoplasm	0.000295	0.00132	CcSEcCtD
Ethosuximide—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000294	0.00132	CcSEcCtD
Ethosuximide—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000293	0.00131	CcSEcCtD
Ethosuximide—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000293	0.00131	CcSEcCtD
Ethosuximide—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000293	0.00131	CcSEcCtD
Ethosuximide—Headache—Vincristine—peripheral nervous system neoplasm	0.000293	0.00131	CcSEcCtD
Ethosuximide—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000288	0.00129	CcSEcCtD
Ethosuximide—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000287	0.00129	CcSEcCtD
Ethosuximide—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000283	0.00127	CcSEcCtD
Ethosuximide—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000282	0.00126	CcSEcCtD
Ethosuximide—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000279	0.00125	CcSEcCtD
Ethosuximide—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000279	0.00125	CcSEcCtD
Ethosuximide—Nausea—Vincristine—peripheral nervous system neoplasm	0.000277	0.00124	CcSEcCtD
Ethosuximide—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000273	0.00122	CcSEcCtD
Ethosuximide—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000272	0.00122	CcSEcCtD
Ethosuximide—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000271	0.00122	CcSEcCtD
Ethosuximide—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000271	0.00121	CcSEcCtD
Ethosuximide—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.00027	0.00121	CcSEcCtD
Ethosuximide—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000269	0.00121	CcSEcCtD
Ethosuximide—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000263	0.00118	CcSEcCtD
Ethosuximide—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000262	0.00117	CcSEcCtD
Ethosuximide—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000261	0.00117	CcSEcCtD
Ethosuximide—Rash—Cisplatin—peripheral nervous system neoplasm	0.00026	0.00117	CcSEcCtD
Ethosuximide—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00026	0.00117	CcSEcCtD
Ethosuximide—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.00026	0.00116	CcSEcCtD
Ethosuximide—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000259	0.00116	CcSEcCtD
Ethosuximide—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000258	0.00116	CcSEcCtD
Ethosuximide—Dizziness—Etoposide—peripheral nervous system neoplasm	0.00025	0.00112	CcSEcCtD
Ethosuximide—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.00025	0.00112	CcSEcCtD
Ethosuximide—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.00025	0.00112	CcSEcCtD
Ethosuximide—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000249	0.00112	CcSEcCtD
Ethosuximide—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000245	0.0011	CcSEcCtD
Ethosuximide—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000242	0.00108	CcSEcCtD
Ethosuximide—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000241	0.00108	CcSEcCtD
Ethosuximide—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.00024	0.00108	CcSEcCtD
Ethosuximide—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000239	0.00107	CcSEcCtD
Ethosuximide—Rash—Etoposide—peripheral nervous system neoplasm	0.000239	0.00107	CcSEcCtD
Ethosuximide—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000238	0.00107	CcSEcCtD
Ethosuximide—Headache—Etoposide—peripheral nervous system neoplasm	0.000237	0.00106	CcSEcCtD
Ethosuximide—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000233	0.00104	CcSEcCtD
Ethosuximide—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000231	0.00104	CcSEcCtD
Ethosuximide—Nausea—Etoposide—peripheral nervous system neoplasm	0.000225	0.00101	CcSEcCtD
Ethosuximide—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000221	0.00099	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.00022	0.000984	CcSEcCtD
Ethosuximide—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000215	0.000964	CcSEcCtD
Ethosuximide—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000208	0.000932	CcSEcCtD
Ethosuximide—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000206	0.000923	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000203	0.000911	CcSEcCtD
Ethosuximide—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000202	0.000906	CcSEcCtD
Ethosuximide—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000192	0.000862	CcSEcCtD
Ethosuximide—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000191	0.000854	CcSEcCtD
Ethosuximide—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000189	0.000845	CcSEcCtD
Ethosuximide—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000187	0.000838	CcSEcCtD
Ethosuximide—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000184	0.000826	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000183	0.00082	CcSEcCtD
Ethosuximide—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000183	0.000819	CcSEcCtD
Ethosuximide—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.000782	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000173	0.000777	CcSEcCtD
Ethosuximide—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.000764	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.000759	CcSEcCtD
Ethosuximide—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.000758	CcSEcCtD
Ethosuximide—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000169	0.000755	CcSEcCtD
Ethosuximide—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000168	0.000751	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000161	0.000719	CcSEcCtD
Ethosuximide—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000156	0.0007	CcSEcCtD
Ethosuximide—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000156	0.000698	CcSEcCtD
Ethosuximide—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000155	0.000695	CcSEcCtD
Ethosuximide—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000682	CcSEcCtD
Ethosuximide—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000145	0.00065	CcSEcCtD
Ethosuximide—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.000648	CcSEcCtD
Ethosuximide—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000631	CcSEcCtD
Ethosuximide—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.00014	0.000628	CcSEcCtD
Ethosuximide—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000604	CcSEcCtD
Ethosuximide—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000602	CcSEcCtD
Ethosuximide—Rash—Epirubicin—peripheral nervous system neoplasm	0.000134	0.000599	CcSEcCtD
Ethosuximide—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000134	0.000599	CcSEcCtD
Ethosuximide—Headache—Epirubicin—peripheral nervous system neoplasm	0.000133	0.000595	CcSEcCtD
Ethosuximide—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.000581	CcSEcCtD
Ethosuximide—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000564	CcSEcCtD
Ethosuximide—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000559	CcSEcCtD
Ethosuximide—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000554	CcSEcCtD
Ethosuximide—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000554	CcSEcCtD
Ethosuximide—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000551	CcSEcCtD
Ethosuximide—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000522	CcSEcCtD
